Novel Rectal Cancer Treatment: Claims Less Risk of Reoccurence and Avoid Surgery, Study Finds
A new treatment for advanced rectal cancer (LARC) called Total neoadjuvant treatment (TNT) has resurfaced and has proved successful enough to avoid surgery and reduce the risk of recurrence, according to a new study published in eClinical Medicine.
Total neoadjuvant treatment (TNT) combines short-course radiotherapy with several rounds of chemotherapy. A study conducted in Sweden revealed that this approach was twice as effective in shrinking tumours compared to earlier methods. Additionally, this treatment has the potential to decrease the necessity for complex bowel surgeries and the associated complications.
For the study, researchers tracked 273 patients with high-risk locally advanced rectal cancer (LARC) across 16 hospitals from July 2016 to June 2020, and an additional 189 patients at 18 hospitals (including the original 16) during the same timeframe. All patients underwent total neoadjuvant treatment (TNT). The study revealed that the proportion of patients with tumour disappearance increased from 14% to 28% compared to earlier treatment regimens, with no rise in recurrence rates.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.